ResearcherThe University of Texas at San Antonio Health Science CenterActive in the last 2 years

Javed Miyan

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5031641475. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2026: 1 paper

Papers 1

The Combination of a BCL-xL PROTAC and an mTOR Inhibitor Sensitizes Pancreatic Ductal Adenocarcinoma to KRAS G12D Inhibitor Treatment. Co-author DOI 10.3390/cancers18060920 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Guangrong Zheng · 1 shared paper, 2026 · strength 0.30
- Paper The Combination of a BCL-xL PROTAC and an mTOR Inhibitor Sensitizes Pancreatic Ductal Adenocarcinoma to KRAS G12D Inhib… DOI 10.3390/cancers18060920 ↗
Vignesh Vudatha · 1 shared paper, 2026 · strength 0.30
- Paper The Combination of a BCL-xL PROTAC and an mTOR Inhibitor Sensitizes Pancreatic Ductal Adenocarcinoma to KRAS G12D Inhib… DOI 10.3390/cancers18060920 ↗
Daohong Zhou · 1 shared paper, 2026 · strength 0.30
- Paper The Combination of a BCL-xL PROTAC and an mTOR Inhibitor Sensitizes Pancreatic Ductal Adenocarcinoma to KRAS G12D Inhib… DOI 10.3390/cancers18060920 ↗
Sajid Ullah Khan · 1 shared paper, 2026 · strength 0.30
- Paper The Combination of a BCL-xL PROTAC and an mTOR Inhibitor Sensitizes Pancreatic Ductal Adenocarcinoma to KRAS G12D Inhib… DOI 10.3390/cancers18060920 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.